All-cause and cardiovascular mortality risk in US adults with and without type 2 diabetes: Influence of physical activity, pharmacological treatment and glycemic control
Aims This study determined the joint association between physical activity,
pharmacotherapy, and HbA1c control on all-cause and cardiovascular disease (CVD) …
pharmacotherapy, and HbA1c control on all-cause and cardiovascular disease (CVD) …
All-cause and cardiovascular mortality risk in US adults with and without type 2 diabetes: Influence of physical activity, pharmacological treatment and glycemic control
RE Brown, MC Riddell… - Journal of diabetes …, 2014 - pubmed.ncbi.nlm.nih.gov
Aims This study determined the joint association between physical activity,
pharmacotherapy, and HbA1c control on all-cause and cardiovascular disease (CVD) …
pharmacotherapy, and HbA1c control on all-cause and cardiovascular disease (CVD) …
All-cause and cardiovascular mortality risk in US adults with and without type 2 diabetes: Influence of physical activity, pharmacological treatment and glycemic control …
RE Brown, MC Riddell, AK Macpherson… - Journal of Diabetes …, 2013 - europepmc.org
Aims This study determined the joint association between physical activity,
pharmacotherapy, and HbA1c control on all-cause and cardiovascular disease (CVD) …
pharmacotherapy, and HbA1c control on all-cause and cardiovascular disease (CVD) …
All-cause and cardiovascular mortality risk in US adults with and without type 2 diabetes: Influence of physical activity, pharmacological treatment and glycemic control
RE Brown, MC Riddell, AK Macpherson… - Journal of Diabetes and …, 2014 - infona.pl
This study determined the joint association between physical activity, pharmacotherapy, and
HbA1c control on all-cause and cardiovascular disease (CVD) mortality risk in adults with …
HbA1c control on all-cause and cardiovascular disease (CVD) mortality risk in adults with …